Urolithin A Attenuates Helicobacter pylori-Induced Damage In Vivo

J Agric Food Chem. 2022 Sep 28;70(38):11981-11993. doi: 10.1021/acs.jafc.2c03711. Epub 2022 Sep 15.

Abstract

Urolithin A (UA) is a metabolite produced in the gut following the consumption of ellagic acid (EA) rich foods. EA has shown anti-inflammatory, antioxidant, and anticancer properties. Because EA is poorly absorbed in the gastrointestinal tract, urolithins are considered to play a major role in bioactivity. Helicobacter pylori (H. pylori) infection is the most common chronic bacterial infection all over the world. It is potentially hazardous to humans because of its relationship to various gastrointestinal diseases. In this study, we investigated the effect of UA on inflammation by H. pylori. The results indicated that UA attenuated H. pylori-induced inflammation in vitro and in vivo. UA also reduced the secretion of H. pylori virulence factors and tissue injuries in mice. Furthermore, UA decreased the relative abundance of Helicobacteraceae in feces of H. pylori-infected mice. In summary, taking UA effectively inhibited the injury caused by H. pylori.

Keywords: H. pylori; anti-inflammatory; intestinal metabolite; urolithin A.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Coumarins / pharmacology
  • Ellagic Acid / metabolism
  • Helicobacter Infections* / drug therapy
  • Helicobacter pylori*
  • Humans
  • Inflammation
  • Mice
  • Virulence Factors

Substances

  • Antioxidants
  • Coumarins
  • Virulence Factors
  • 3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one
  • Ellagic Acid